Journal of Oncology Pharmacy Practice

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tans, B.
Right arrow Articles by Willems, L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Tans, B.
Right arrow Articles by Willems, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Oncology Pharmacy Practice, Vol. 10, No. 4, 217-223 (2004)
DOI: 10.1191/1078155204jp140oa
© 2004 SAGE Publications

Comparative contamination study with cyclophosphamide, fluorouracil and ifosfamide: standard technique versus a proprietary closed-handling system

Birgit Tans

Ludo Willems

Introduction. In 2003 more than 55 000 preparations of injectable hazardous drugs were made in the central admixture service of the University Hospital in Leuven, Belgium. According to the literature, surface contamination occurs, despite the use of special equipment and procedures. The objective of this study was to compare the surface and glove contamination with cyclophosphamide, ifosfamide and fluorouracil, following preparation using either a standard admixture technique or the fully enclosed PhaSeal® system.

Method. During a period of 4 months cyclophosphamide and fluorouracil were prepared with the PhaSeal® system. Following a period of 2 months using the classical technique, cyclophosphamide and ifosfamide were prepared for an 18-month period with the PhaSeal® system. Samples were taken before the start of the 4-month period, in the middle and at the end of the PhaSeal® period, 2 months after stopping PhaSeal® and again after 18 months of working with PhaSeal®. The total number of samples was 104.

Results. For fluorouracil only one of the 14 surface samples was detectable, probably because the detection limit is too high. No differences between the results of the surface samples for cyclophosphamide and ifosfamide were detected. However, a rather big spill due to incorrect use of the system could have influenced these results. Differences in contamination on the gloves were more important.

Conclusion. Good compliance with standard preparation and cleaning techniques results in equal levels of contamination on surfaces compared with the PhaSeal® system. However, the PhaSeal® system is an important improvement in reducing contamination on gloves.

Key Words: contamination • cyclophosphamide cytotoxic drugs • fluorouracil • hazardous drugs • ifosfamide • surfaces


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J Oncol Pharm PractHome page
Section 7 Special devices
Journal of Oncology Pharmacy Practice, September 1, 2007; 13(3_suppl): 27 - 30.
[PDF]


Home page
Am J Health Syst PharmHome page
B. R. Harrison, B. G. Peters, and M. R. Bing
Comparison of surface contamination with cyclophosphamide and fluorouracil using a closed-system drug transfer device versus standard preparation techniques.
Am. J. Health Syst. Pharm., September 15, 2006; 63(18): 1736 - 1744.
[Abstract] [Full Text] [PDF]